Engineer told building managers there was ‘major structural damage’ at condo in 2018, report shows
Engineers who evaluated the South Florida condo that partially collapsed Thursday, leaving dozens trapped under the rubble, warned in a 2018 report of a “major error” in the construction’s original development. The report notes that the building's reinforced concrete slab is not sloped to drain.
/cloudfront-us-east-1.images.arcpublishing.com/bostonglobe/ZSSU57I22AGKFPODLRW5Z4IDW4.jpg)
A glittering reminder on the Boston skyline that buildings can have hidden problems
The reason for the shocking Florida building collapse is not known, but the tragedy unfolding there has many people questioning the safety of our buildings. The history of Boston's soaring Hancock Tower is a reminder that even the most impressive can have problems not visible to the eye.
Boston building officials outline city safety measures
When it happened here: In 1987, L’Ambiance Plaza collapsed in Conn. Years before that, a similar tragedy in Brighton
Should you be worried about your building coming down? We asked an expert
The reason for the shocking Florida building collapse is not known, but the tragedy unfolding there has many people questioning the safety of our buildings. The history of Boston's soaring Hancock Tower is a reminder that even the most impressive can have problems not visible to the eye.
Alex Speier | RED SOX 5, YANKEES 3
/cloudfront-us-east-1.images.arcpublishing.com/bostonglobe/WDAS5RYHP4YDB4UNG75XPWTICI.jpg)
Nights like these reinforce the Red Sox’ beliefs
The team’s consistency has allowed it to recalibrate its ambitions.
‘It means the world to me to be a Red Sox:’ Dustin Pedroia gets fitting farewell at Fenway
Dan Shaughnessy: Still not sold on this iteration of Red Sox-Yankees
The team’s consistency has allowed it to recalibrate its ambitions.
Mass. coronavirus at a glance |
/cloudfront-us-east-1.images.arcpublishing.com/bostonglobe/TUZB7IPLW2ZWUB7FFLSLDARZQY.jpg)
Biogen says pricey new Alzheimer’s drug reflects treatment’s overall value. Critics vehemently disagree
Amid the fierce backlash over the $56,000 annual price tag for its controversial new Alzheimer’s drug, Biogen is emphasizing another rationale beyond the benefits of reducing the staggering toll of the illness: Other novel medicines using similar technology are much more expensive.
State’s second-largest health insurer slams Biogen for costly Alzheimer’s drug
Amid the fierce backlash over the $56,000 annual price tag for its controversial new Alzheimer’s drug, Biogen is emphasizing another rationale beyond the benefits of reducing the staggering toll of the illness: Other novel medicines using similar technology are much more expensive.
Support Real Journalism
Subscribe to the Globe for just 99 cents
